These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9399100)

  • 21. Circulating tumour necrosis factor alpha & soluble TNF receptors in patients with Guillain-Barre syndrome.
    Radhakrishnan VV; Sumi MG; Reuben S; Mathai A; Nair MD
    Indian J Med Res; 2003 May; 117():216-20. PubMed ID: 14609050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-tumor necrosis factor-α antibodies induce regulatory macrophages in an Fc region-dependent manner.
    Vos AC; Wildenberg ME; Duijvestein M; Verhaar AP; van den Brink GR; Hommes DW
    Gastroenterology; 2011 Jan; 140(1):221-30. PubMed ID: 20955706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.
    Leontyev D; Katsman Y; Ma XZ; Miescher S; Käsermann F; Branch DR
    Transfusion; 2012 Aug; 52(8):1799-805. PubMed ID: 22257295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of immunoglobulin production in vitro by IgG and F(ab')2 fragments, but not by the Fc portion.
    Klaesson S; Tammik L; Markling L; Lundkvist I; Ringdén O
    Scand J Immunol; 1996 May; 43(5):574-82. PubMed ID: 8633217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors.
    Stangel M; Compston A
    J Neuroimmunol; 2001 Jan; 112(1-2):63-71. PubMed ID: 11108934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulin modulates human mononuclear phagocyte tumor necrosis factor-alpha production in vitro.
    Darville T; Tabor D; Simpson K; Jacobs RF
    Pediatr Res; 1994 Apr; 35(4 Pt 1):397-403. PubMed ID: 8047375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 7th International Immunoglobulin Conference: Mechanisms of action.
    Basta M; Branch DR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):111. PubMed ID: 25546783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptome Analysis of Peripheral Blood in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients Identifies TNFR1 and TLR Pathways in the IVIg Response.
    Richard A; Corvol JC; Debs R; Reach P; Tahiri K; Carpentier W; Gueguen J; Guillemot V; Labeyrie C; Adams D; Viala K; Cohen Aubart F
    Medicine (Baltimore); 2016 May; 95(19):e3370. PubMed ID: 27175635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production.
    Tawfik DS; Cowan KR; Walsh AM; Hamilton WS; Goldman FD
    Pediatr Allergy Immunol; 2012 Feb; 23(1):88-95. PubMed ID: 21265884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effect of pooled human immunoglobulin on cytokine production in peripheral blood mononuclear cells.
    Wu KH; Wu WM; Lu MY; Chiang BL
    Pediatr Allergy Immunol; 2006 Feb; 17(1):60-8. PubMed ID: 16426257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous immunoglobulins suppress immunoglobulin productions by suppressing Ca(2+)-dependent signal transduction through Fc gamma receptors in B lymphocytes.
    Kondo N; Kasahara K; Kameyama T; Suzuki Y; Shimozawa N; Tomatsu S; Nakashima Y; Hori T; Yamagishi A; Ogawa T
    Scand J Immunol; 1994 Jul; 40(1):37-42. PubMed ID: 8029641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of IgE production in vitro by intact and fragmented intravenous immunoglobulin.
    Zhuang Q; Mazer B
    J Allergy Clin Immunol; 2001 Aug; 108(2):229-34. PubMed ID: 11496239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An immunoglobulin agent (IVIG) inhibits NF-kappaB activation in cultured endothelial cells of coronary arteries in vitro.
    Ichiyama T; Ueno Y; Isumi H; Niimi A; Matsubara T; Furukawa S
    Inflamm Res; 2004 Jun; 53(6):253-6. PubMed ID: 15167972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutralization of mitogenic lectins by intravenous immunoglobulin (IVIg) prevents T cell activation: does IVIg really have a direct effect on T cells?
    Padet L; St-Amour I; Aubin É; Bazin R
    Clin Exp Immunol; 2011 Dec; 166(3):352-60. PubMed ID: 22059993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of action of intravenous immune globulin in immune-mediated diseases.
    Mouthon L; Kaveri SV; Spalter SH; Lacroix-Desmazes S; Lefranc C; Desai R; Kazatchkine MD
    Clin Exp Immunol; 1996 May; 104 Suppl 1():3-9. PubMed ID: 8625540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IVIG inhibits TNF-α-induced MMP9 expression and activity in monocytes by suppressing NF-κB and P38 MAPK activation.
    Zhou C; Huang M; Xie L; Shen J; Xiao T; Wang R
    Int J Clin Exp Pathol; 2015; 8(12):15879-86. PubMed ID: 26884859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
    Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
    Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mechanisms of action of intravenous immunoglobulins in the treatment of autoimmune diseases].
    Mouthon L; Hurez V; Kazatchkine M
    Ann Med Interne (Paris); 1993; 144(8):506-13. PubMed ID: 8179238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use.
    Kaveri S; Vassilev T; Hurez V; Lengagne R; Lefranc C; Cot S; Pouletty P; Glotz D; Kazatchkine MD
    J Clin Invest; 1996 Feb; 97(3):865-9. PubMed ID: 8609246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.